Advanced search
Publication Cover
Renal Failure Volume 32, 2010 - Issue 3
Submit an article Journal homepage
863
Views
12
CrossRef citations to date
0
Altmetric
Clinical Studies

Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience

Sifil Aykut Division of Nephrology, Faculty of Medicine, Dokuz Eylul University, Izmir, TurkeyCorrespondence[email protected]
,
Cavdar Caner Division of Nephrology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey
,
Gungor Ozkan Division of Nephrology, Faculty of Medicine, Ege University, Izmir, Turkey
,
Celik Ali Division of Nephrology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey
,
Atay Tugba Division of Clinical Microbiology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey
,
Gulay Zeynep Division of Clinical Microbiology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey
&
Camsari Taner Division of Nephrology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey
 show all
Pages 356-361 | Received 20 Oct 2009, Accepted 23 Nov 2009, Published online: 06 Apr 2010

REFERENCES

  • Keogh AM. Complications in peritoneal dialysis peritonitis and exit site infections. Perit Dial Int. 1996;16:S464–S467.
  • Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol. 1996;7:2176–2182.
  • Grupta B, Bernardini J, Piraino B. Peritonitis associated with exit site and tunnel infections. Am J Kidney Dis. 1996;28:415–419.
  • Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Treatment of S. aureus nasal carriers in CAPD with mupirocin. Adv Perit Dial. 1992;8:242–245.
  • Bernardini J, Piraino B, Holley J, Juhnston JR, Lutes R. A randomized trial of S. aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to exit site versus cyclic oral rifampin. Am J Kidney Dis. 1996;27:695–700.
  • Chu KH, Choy WY, Cheung CC, Prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections. Perit Dial Int. 2008;28:505–508.
  • Xu G, Tu W, Xu C. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Nephrol Dial Transplant. 2010;25:587–592.
  • Ward A, Campoli-Richards DM. Mupirocin. A rewiew of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1986;32:425–444.
  • Mahajan S, Tiwari S, Kalra V, Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population. Perit Dial Int. 2005;25:473–477.
  • Uttley L, Vardhan A, Mahajan S, Smart B, Hutchinson A, Gokal R. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit-site. J Nephrol. 2004;17:242–245.
  • Thodis E, Bhaskaran S, Passadakis P, Bargman JM, Vas SI, Oreopoulos DG. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at catheter exit site. Perit Dial Int. 1998;18:261–270.
  • Cavdar C, Saglam F, Sifil A, Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: Three years of experience. Ren Fail. 2008;30:417–422.
  • Rosales M, Perez-Fontan M, Rodriguez-Carmona A, Garcia-Falcon T. Increasing resistance to mupirocin of S. aureus strains isolated from peritoneal dialysis patients and their partners: Long term study. Perit Dial Int. 2001;21:S218.
  • Peritoneal Dialysis–Related Infections Recommendations: 2005 Update. Perit Dial Int. 2005;25:107–131.
  • Casey M, Taylor J, Clinard P, Application of mupirocin cream at the catheter exit site reduces exit cite infections and peritonitis in peritoneal dialysis patients. Perit Dial Int. 2000;20:566–568.
  • Annigeri R, Conly J, Vas S, Emergence of mupirocin–resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int. 2001;21:554–559.
  • Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Falcon TG, Valdes F. Mupirocin resistance after long-term use Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis. 2002;39:337–341.
  • Lobbedez T, Gardam M, Dedier H, Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: Still low after 7 years. Nephrol Dial Transplant. 2004;19:3140–3143.
  • Kesli R, Cander S, Celebi S. Fusidic acid resistance of S. aureus. Med J Kocatepe. 2004;5:33–36.
  • Lim CT, Wong KS, Foo MW. The impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital. Nephrol Dial Transplant. 2005;20:2202–2206.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.